Both increased stability and transcription contribute to the induction of the urokinase plasminogen activator receptor (uPAR) message by hypoxia

Experimental Cell Research

Volumn 255, Issue 2, 2000, Pages 250-257

  Maity, Amit ^a   Solomon, Don ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Hypoxia; RNA stability; Transcription; UPAR

Indexed keywords

DACTINOMYCIN; MESSENGER RNA; UROKINASE;

ARTICLE; CELL HYPOXIA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN STABILITY; REOXYGENATION; RNA ANALYSIS; TRANSCRIPTION REGULATION;

EID: 0034653379     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4804     Document Type: Article

References (65)

1. Vaupel P., Thews O., Kelleher D. K., Hoeckel M. Current status of knowledge and critical issues in tumor oxygenation. Results from 25 years research in tumor pathophysiology. Adv. Exp. Med. Biol. 454:1998;591-602.
2. 2 tension measurements. Cancer Res. 51:1991;3316-3322.
3. Brizel D. M., Scully S. P., Harrelson J. M., Layfield L. J., Bean J. M., Prosnitz L. R., Dewhirst M. W. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res. 56:1996;941-943.
4. Fyles A. W., Milosevic M., Wong R., Kavanagh M. C., Pintilie M., Sun A., Chapman W., Levin W., Manchul L., Keane T. J., Hill R. P. Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiother. Oncol. 48:1998;149-156.
5. Hockel M., Schlenger K., Aral B., Mitze M., Schaffer U., Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 56:1996;4509-4515.
6. Brizel D. M., Sibley G. S., Prosnitz L. R., Scher R. L., Dewhirst M. W. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int. J. Radiat. Oncol. Biol. Phys. 38:1997;285-289.
7. Jang A., Hill R. P. An examination of the effects of hypoxia, acidosis, and glucose starvation on the expression of metastasis-associated genes in murine tumor cells. Clin. Exp. Metastasis. 15:1997;469-483.
8. Young S. D., Marshall R. S., Hill R. P. Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. Proc. Natl. Acad. Sci. USA. 85:1988;9533-9537.
9. Cuvier C., Jang A., Hill R. P. Exposure to hypoxia, glucose starvation and acidosis: Effect on invasive capacity of murine tumor cells and correlation with cathepsin (L + B) secretion. Clin. Exp. Metastasis. 15:1997;19-25.
10. Reynolds T. Y., Rockwell S., Glazer P. M. Genetic instability induced by the tumor microenvironment. Cancer Res. 56:1996;5754-5757.
11. Rice G. C., Hoy C., Schimke R. T. Transient hypoxia enhances the frequency of dihydrofolate reductase gene amplification in Chinese hamster ovary cells. Proc. Natl. Acad. Sci. USA. 83:1986;5978-5982.
12. Graeber T. G., Osmanian C., Jacks T., Housman D. E., Koch C. J., Lowe S. W., Giaccia A. J. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours [see comments]. Nature. 379:1996;88-91.
13. Graham C. H., Fitzpatrick T. E., McCrae K. R. Hypoxia stimulates urokinase receptor expression through a heme protein-dependent pathway. Blood. 91:1998;3300-3307.
14. Graham C. H., Forsdike J., Fitzgerald C. J., Macdonald-Goodfellow S. Hypoxia-mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression. Int. J. Cancer. 80:1999;617-623.
15. Blasi F., Stoppelli M. P. Proteases and cancer invasion: From belief to certainty. AACR meeting on proteases and protease inhibitors in cancer, Nyborg, Denmark, 14-18 June 1998. Biochim. Biophys. Acta. 1423:1999;R35-R44.
16. Edwards D. R., Murphy G. Cancer. Proteases - Invasion and more [news]. Nature. 394:1998;527-528.
17. Blasi F. uPA, uPAR, PAI-1: Key intersection of proteolytic, adhesive and chemotactic highways. Immunol. Today. 18:1997;415-417.
18. Bugge T. H., Lund L. R., Kombrinck K. K., Nielsen B. S., Holmback K., Drew A. F., Flick M. J., Witte D. P., Dano K., Degen J. L. Reduced metastasis of polyoma virus middle T antigen-induced mammary cancer in plasminogen-deficient mice. Oncogene. 16:1998;3097-3104.
19. Gladson C. L., Pijuan-Thompson V., Olman M. A., Gillespie G. Y., Yacoub I. Z. Up-regulation of urokinase and urokinase receptor genes in malignant astrocytoma. Am. J. Pathol. 146:1995;1150-1160.
20. de Vries T. J., Quax P. H., Denijn M., Verrijp K. N., Verheijen J. H., Verspaget H. W., Weidle U. H., Ruiter D. J., van Muijen G. N. Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression. Am. J. Pathol. 144:1994;70-81.
21. Duggan C., Maguire T., McDermott E., O'Higgins N., Fennelly J. J., Duffy M. J. Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer. Int. J. Cancer. 61:1995;597-600.
22. Costantini V., Sidoni A., Deveglia R., Cazzato O. A., Bellezza G., Ferri I., Bucciarelli E., Nenci G. G. Combined overexpression of urokinase, urokinase receptor, and plasminogen activator inhibitor-1 is associated with breast cancer progression: An immunohistochemical comparison of normal, benign, and malignant breast tissues. Cancer. 77:1996;1079-1088.
23. Pyke C., Kristensen P., Ralfkiaer E., Grondahl-Hansen J., Eriksen J., Blasi F., Dano K. Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas. Am. J. Pathol. 138:1991;1059-1067.
24. Cantero D., Friess H., Deflorin J., Zimmermann A., Brundler M. A., Riesle E., Korc M., Buchler M. W. Enhanced expression of urokinase plasminogen activator and its receptor in pancreatic carcinoma. Br. J. Cancer. 75:1997;388-395.
25. Pedersen H., Brunner N., Francis D., Osterlind K., Ronne E., Hansen H. H., Dano K., Grondahl-Hansen J. Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue. Cancer Res. 54:1994;4671-4675.
26. Casslen B., Gustavsson B., Astedt B. Cell membrane receptors for urokinase plasminogen activator are increased in malignant ovarian tumours. Eur. J. Cancer. 27:1991;1445-1448.
27. Bianchi E., Cohen R. L., Thor A. T., Todd R. F. III, Mizukami I. F., Lawrence D. A., Ljung B. M., Shuman M. A., Smith H. S. The urokinase receptor is expressed in invasive breast cancer but not in normal breast tissue. Cancer Res. 54:1994;861-866.
28. Del Vecchio S., Stoppelli M. P., Carriero M. V., Fonti R., Massa O., Li P. Y., Botti G., Cerra M., D'Aiuto G., Esposito G. Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography: Comparison with urokinase levels. Cancer Res. 53:1993;3198-3206.
29. Kariko K., Kuo A., Boyd D., Okada S. S., Cines D. B., Barnathan E. S. Overexpression of urokinase receptor increases matrix invasion without altering cell migration in a human osteosarcoma cell line. Cancer Res. 53:1993;3109-3117.
30. Xing R. H., Mazar A., Henkin J., Rabbani S. A. Prevention of breast cancer growth, invasion, and metastasis by antiestrogen tamoxifen alone or in combination with urokinase inhibitor B-428. Cancer Res. 57:1997;3585-3593.
31. Hollas W., Blasi F., Boyd D. Role of the urokinase receptor in facilitating extracellular matrix invasion by cultured colon cancer. Cancer Res. 51:1991;3690-3695.
32. Stahl A., Mueller B. M. Binding of urokinase to its receptor promotes migration and invasion of human melanoma cells in vitro. Cancer Res. 54:1994;3066-3071.
33. Quattrone A., Fibbi G., Anichini E., Pucci M., Zamperini A., Capaccioli S., Del Rosso M. Reversion of the invasive phenotype of transformed human fibroblasts by anti-messenger oligonucleotide inhibition of urokinase receptor gene expression. Cancer Res. 55:1995;90-95.
34. Mohanam S., Chintala S. K., Go Y., Bhattacharya A., Venkaiah B., Boyd D., Gokaslan Z. L., Sawaya R., Rao J. S. In vitro inhibition of human glioblastoma cell line invasiveness by antisense uPA receptor. Oncogene. 14:1997;1351-1359.
35. Kook Y. H., Adamski J., Zelent A., Ossowski L. The effect of antisense inhibition of urokinase receptor in human squamous cell carcinoma on malignancy. EMBO J. 13:1994;3983-3991.
36. Ignar D. M., Andrews J. L., Witherspoon S. M., Leray J. D., Clay W. C., Kilpatrick K., Onori J., Kost T., Emerson D. L. Inhibition of establishment of primary and micrometastatic tumors by a urokinase plasminogen activator receptor antagonist. Clin. Exp. Metastasis. 16:1998;9-20.
37. Crowley C. W., Cohen R. L., Lucas B. K., Liu G., Shuman M. A., Levinson A. D. Prevention of metastasis by inhibition of the urokinase receptor. Proc. Natl. Acad. Sci. USA. 90:1993;5021-5025.
38. Min H. Y., Doyle L. V., Vitt C. R., Zandonella C. L., Stratton-Thomas J. R., Shuman M. A., Rosenberg S. Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice. Cancer Res. 56:1996;2428-2433.
39. Evans C. P., Elfman F., Parangi S., Conn M., Cunha G., Shuman M. A. Inhibition of prostate cancer neovascularization and growth by urokinase-plasminogen activator receptor blockade. Cancer Res. 57:1997;3594-3599.
40. Koch C. J. A thin-film culturing technique allowing rapid gas-liquid equilibration (6 sec) with no toxicity to mammalian cells. Radiat. Res. 97:1984;434-442.
41. Koch C. J., Kruuv J., Frey H. E. Variation in radiation response of mammalian cells as a function of oxygen tension. Radiat. Res. 53:1973;33-42.
42. Suh T. T., Nerlov C., Dano K., Degen J. L. The murine urokinase-type plasminogen activator receptor gene. J. Biol. Chem. 269:1994;25992-25998.
43. Pinsky D. J., Liao H., Lawson C. A., Yan S. F., Chen J., Carmeliet P., Loskutoff D. J., Stern D. M. Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promote pulmonary vascular fibrin deposition. J. Clin. Invest. 102:1998;919-928.
44. Fitzpatrick T. E., Graham C. H. Stimulation of plasminogen activator inhibitor-1 expression in immortalized human trophoblast cells cultured under low levels of oxygen. Exp. Cell Res. 245:1998;155-162.
45. Lund L. R., Ellis V., Ronne E., Pyke C., Dano K. Transcriptional and post-transcriptional regulation of the receptor for urokinase-type plasminogen activator by cytokines and tumour promoters in the human lung carcinoma cell line A549. Biochem. J. 310:1995;345-352.
46. Shetty S., Kumar A., Idell S. Posttranscriptional regulation of urokinase receptor mRNA: Identification of a novel urokinase receptor mRNA binding protein in human mesothelioma cells. Mol. Cell. Biol. 17:1997;1075-1083.
47. Levy A. P., Levy N. S., Goldberg M. A. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J. Biol. Chem. 271:1996;2746-2753.
48. Ikeda E., Achen M. G., Breier G., Risau W. Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J. Biol. Chem. 270:1995;19761-19766.
49. Stein I., Neeman M., Shweiki D., Itin A., Keshet E. Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Mol. Cell. Biol. 15:1995;5363-5368.
50. Levy A. P., Levy N. S., Goldberg M. A. Hypoxia-inducible protein binding to vascular endothelial growth factor mRNA and its modulation by the von Hippel-Lindau protein. J. Biol. Chem. 271:1996;25492-25497.
51. Levy N. S., Chung S., Furneaux H., Levy A. P. Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR. J. Biol. Chem. 273:1998;6417-6423.
52. Czyzyk-Krzeska M. F., Furnari B. A., Lawson E. E., Millhorn D. E. Hypoxia increases rate of transcription and stability of tyrosine hydroxylase mRNA in pheochromocytoma (PC12) cells. J. Biol. Chem. 269:1994;760-764.
53. Goldberg M. A., Gaut C. C., Bunn H. F. Erythropoietin mRNA levels are governed by both the rate of gene transcription and posttranscriptional events. Blood. 77:1991;271-277.
54. Shetty S., Idell S. A urokinase receptor mRNA binding protein-mRNA interaction regulates receptor expression and function in human pleural mesothelioma cells. Arch. Biochem. Biophys. 356:1998;265-279.
55. Wang G. J., Collinge M., Blasi F., Pardi R., Bender J. R. Posttranscriptional regulation of urokinase plasminogen activator receptor messenger RNA levels by leukocyte integrin engagement. Proc. Natl. Acad. Sci. USA. 95:1998;6296-6301.
56. 2 homeostasis. Curr. Opin. Genet. Dev. 8:1998;588-594.
57. Ratcliffe P. J., O'Rourke J. F., Maxwell P. H., Pugh C. W. Oxygen sensing, hypoxia-inducible factor-1 and the regulation of mammalian gene expression. J. Exp. Biol. 201:1998;1153-1162.
58. Semenza G. L., Roth P. H., Fang H. M., Wang G. L. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J. Biol. Chem. 269:1994;23757-23763.
59. Yao K. S., Xanthoudakis S., Curran T., O'Dwyer P. J. Activation of AP-1 and of a nuclear redox factor, Ref-1, in the response of HT29 colon cancer cells to hypoxia. Mol. Cell. Biol. 14:1994;5997-6003.
60. Yan S. F., Lu J., Zou Y. S., Soh-Won J., Cohen D. M., Buttrick P. M., Cooper D. R., Steinberg S. F., Mackman N., Pinsky D. J., Stern D. M. Hypoxia-associated induction of early growth response-1 gene expression. J. Biol. Chem. 274:1999;15030-15040.
61. Discher D. J., Bishopric N. H., Wu X., Peterson C. A., Webster K. A. Hypoxia regulates beta-enolase and pyruvate kinase-M promoters by modulating Sp1/Sp3 binding to a conserved GC element. J. Biol. Chem. 273:1998;26087-26093.
62. Murphy B. J., Andrews G. K., Bittel D., Discher D. J., McCue J., Green C. J., Yanovsky M., Giaccia A., Sutherland R. M., Laderoute K. R., Webster K. A. Activation of metallothionein gene expression by hypoxia involves metal response elements and metal transcription factor-1. Cancer Res. 59:1999;1315-1322.
63. Waleh N. S., Calaoagan J., Murphy B. J., Knapp A. M., Sutherland R. M., Laderoute K. R. The redox-sensitive human antioxidant responsive element induces gene expression under low oxygen conditions. Carcinogenesis. 19:1998;1333-1337.
64. Meyuhas O., Perry R. P. Construction and identification of cDNA clones for mouse ribosomal proteins: Application for the study of r-protein gene expression. Gene. 10:1980;113-129.
65. Kindy M. S., Sonenshein G. E. Regulation of oncogene expression in cultured aortic smooth muscle cells. Post-transcriptional control of c-myc mRNA. J. Biol. Chem. 261:1986;12865-12868.